Albornoz L, Alvarez D, Otaso J C, Gadano A, Salviú J, Gerona S, Sorroche P, Villamil A, Mastai R
Sección de Higado, Laboratorio Central, Hospital Italiano, Buenos Aires, Argentina.
J Hepatol. 1999 Mar;30(3):451-5. doi: 10.1016/s0168-8278(99)80104-4.
BACKGROUND/AIMS: The aim of this study was to evaluate the relationship between plasma levels of von Willebrand factor (vWF), a marker of endothelial cell activation, and nitric oxide, a powerful vasodilator synthesized by endothelial cells, in 27 patients with cirrhosis at different stages of the disease. These results were compared with those of age-matched normal, healthy subjects (n=10).
vWF:antigen was measured by electro-immunodiffusion test and serum nitrite and nitrate levels, the stable end products of nitric oxide metabolism, were determined by an enzymatic procedure.
vWF:antigen and nitrite/nitrate levels were significantly higher in cirrhotic patients (367+/-185% and 29.3+/-10.8 micromol/l) than in healthy subjects (92+/-20% and 19.2+/-8.3 micromol/l, p<0.05, respectively). Higher levels of vWF:antigen and nitrites/nitrates were observed in patients with more advanced degrees of liver failure, as reflected by quantitative Child-Pugh's score (516+/-154% and 38.3+/-7.8 micromol/l in Child-Pugh > or = 9 vs 227+/-61% and 21.0+/-6.1 micromol/l in Child-Pugh <9, p<0.001, respectively). Moreover, both endothelial-related factors were higher in patients with ascites than those without ascites (543+/-158% and 37.8+/-8.9 micromol/l vs 262+/-103% and 24.4+/-8.8 micromol/l, p<0.001, respectively). In the overall series, a highly significant linear correlation between nitrites/nitrates and vWF:antigen levels was observed in patients with cirrhosis (r=0.79, p<0.001).
These results support a cirrhosis-related endothelial dysfunction and suggest that plasma vWF measurement could be useful as a marker of endothelial disturbance in patients with cirrhosis.
背景/目的:本研究旨在评估27例处于不同疾病阶段的肝硬化患者中,血管性血友病因子(vWF)(一种内皮细胞活化标志物)的血浆水平与一氧化氮(一种由内皮细胞合成的强效血管舒张剂)之间的关系。将这些结果与年龄匹配的正常健康受试者(n = 10)的结果进行比较。
采用电免疫扩散试验测定vWF抗原,通过酶促法测定血清亚硝酸盐和硝酸盐水平(一氧化氮代谢的稳定终产物)。
肝硬化患者的vWF抗原和亚硝酸盐/硝酸盐水平(分别为367±185%和29.3±10.8μmol/L)显著高于健康受试者(分别为92±20%和19.2±8.3μmol/L,p<0.05)。根据Child-Pugh定量评分,在肝功能衰竭程度更严重的患者中观察到更高水平的vWF抗原和亚硝酸盐/硝酸盐(Child-Pugh≥9的患者中分别为516±154%和38.3±7.8μmol/L,而Child-Pugh<9的患者中分别为227±61%和21.0±6.1μmol/L,p<0.001)。此外,有腹水的患者的两种内皮相关因子均高于无腹水的患者(分别为543±158%和37.8±8.9μmol/L vs 262±103%和24.4±8.8μmol/L,p<0.001)。在整个研究组中,肝硬化患者的亚硝酸盐/硝酸盐水平与vWF抗原水平之间存在高度显著的线性相关性(r = 0.79,p<0.001)。
这些结果支持肝硬化相关的内皮功能障碍,并表明血浆vWF检测可能有助于作为肝硬化患者内皮功能紊乱的标志物。